Ex-RFK Jr Adviser Demands Records On Wiles's Health Policy Influence
Calley Means alleges Susie Wiles led the Trump administration to favor corporate interests on health policy, sparking concerns over her potential impact on health policy decisions

Story timeline2 updates
Susie Wiles has left the White House as Chief of Staff.
Story published. Calley Means alleges Susie Wiles led the Trump administration to favor corporate interests on health policy, sparking concerns over her potential impact on health policy decisions
A former top adviser to Health Secretary Robert F. Kennedy Jr. has requested records on Susie Wiles's health policy influence to be preserved. Calley Means made the request following allegations that Wiles, a former White House chief of staff, led the Trump administration to consistently bow to corporate interests on health policy.
Calley Means is a former adviser to Health Secretary Robert F. Kennedy Jr. and has recently spoken out about his concerns over Wiles's potential impact on health policy decisions. Means appeared on Face the Nation with Rep.-elect Nancy Lacore, where he discussed his allegations against Wiles.
The request to preserve records on Wiles's health policy influence comes amid concerns that the Trump administration may have prioritized corporate interests over public health. Means's allegations suggest that Wiles played a significant role in shaping the administration's health policy decisions.
## Why it matters The preservation of records on Wiles's health policy influence is crucial in understanding the extent of corporate influence on the Trump administration's health policy decisions. The allegations made by Calley Means raise important questions about the administration's priorities and the potential impact on public health. As the administration's health policy decisions have far-reaching consequences, it is essential to examine the role of corporate interests in shaping these decisions.
The request for records preservation is a significant development in the ongoing debate over the influence of corporate interests on health policy. It highlights the need for transparency and accountability in the decision-making process, ensuring that public health interests are prioritized over corporate interests.




